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ABSTRACT
U1 snRNP plays a crucial role in the 5’ splice site rec-
ognition during splicing. Here we report the first
example of naturally occurring U1-independent
U2-type splicing in humans. The U1 components
were not included in the pre-spliceosomal E com-
plex formed on the human F1c (hF1c) intron 9
in vitro. Moreover, hF1c intron 9 was efficiently
spliced even in U1-disrupted Xenopus oocytes as
well as in U1-inactivated HeLa nuclear extracts.
Finally, hF1c exon 9 skipping induced by an alterna-
tive splicing regulator Fox-1 was impaired when
intron 9 was changed to the U1-dependent one.
Our results suggest that U1-independent splicing
contributes to the regulation of alternative splicing
of a class of pre-mRNAs.
INTRODUCTION
Alternative pre-mRNA splicing is one of the central
mechanisms for the regulation of gene expression in
eukaryotic cells. It allows the generation of multiple pro-
teins from a single gene. It has been estimated that more
than 70% of human gene are alternatively spliced.
Moreover, alternative splicing is often regulated in a
spatio-temporal manner (1–4).
Pre-mRNA splicing is catalyzed by a large ribonucleo-
protein complex called the spliceosome, which contains
ﬁve small nuclear ribonucleoproteins (snRNPs), U1, U2,
U4, U5 and U6, as well as many protein-splicing factors.
Spliceosome assembly occurs in an ordered manner within
each intron. The initial step for spliceosome formation is
assembly of the E complex: U1 snRNP binds to the 50
splice site, SF1 (BBP) binds to the branchpoint, U2AF
binds to the 30 splice site and U2 snRNP loosely associates
(5). As the E complex assembly is a key step for exon
deﬁnition, it is regulated by several nonspliceosomal
RNA-binding proteins, including SR proteins, hnRNP
proteins and tissue-speciﬁc splicing regulators. These
RNA-binding proteins bind to various types of exonic
and intronic elements and modulate the use of nearby
splice sites. SR proteins bind to purine-rich exonic splicing
enhancers (ESEs) to activate the splicing reaction. They
stimulate recognition of the 50 splice site by recruitment of
U1 snRNP and also increase the eﬃciency of recruiting
U2AF to the 30 splice site, leading to U2 snRNP associa-
tion (6). In contrast, hnRNP proteins bind to exonic splic-
ing silencers (ESSs) and intronic splicing silencers (ISSs),
and repress the splicing reaction by interfering with the
binding of SR proteins, U1 snRNP or U2AF (7). In addi-
tion, several tissue-speciﬁc splicing regulators aﬀect the
E complex formation (8,9).
We have focused on the mechanism of tissue-speciﬁc
splicing that is controlled by Fox-1. Fox-1 is expressed
in the brain, heart and skeletal muscle in mammals and
regulates tissue-speciﬁc splicing of several genes including
human mitochondrial ATP synthase g subunit gene
(hF1g), nonmuscle myosin heavy chain (NMHC-B) and
c-src via binding to the (U)GCAUG element (10–12). In a
previous study using in vivo and in vitro splicing assays, we
showed that Fox-1 induces hF1g exon 9 skipping by inter-
fering with the formation of the E complex on intron 9
through binding to the GCAUG element in intron 8 (13).
In this study, we performed aﬃnity puriﬁcation of the
E complex on hF1g intron 9 (hF1g exon 9–10) to clarify
the mechanism of how the E complex formation is inhib-
ited by Fox-1. Unexpectedly, we found that the E complex
formed on the hF1g exon 9–10 pre-mRNA did not contain
U1 snRNP even in the absence of Fox-1, although the pre-
mRNA was spliced with high eﬃciency. Moreover, hF1g
intron 9 was successfully spliced in U1-disrupted Xenopus
oocyte as well as in U1-inactivated HeLa cell nuclear
extracts, indicating that hF1g exon 9–10 is a natural
U1-independent splicing substrate. It has been reported
that a class of pre-mRNAs can be spliced in U1 snRNP-
depleted HeLa nuclear extracts with enriched SR protein
(14,15). In addition, Drosophila fushi-tarazu (ftz) pre-
mRNA can be spliced in the U1-depleted HeLa nuclear
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However, the mechanism and biological signiﬁcance of
naturally occurring U1-independent splicing is unclear.
As compared with the consensus of the canonical 50
splice site, the positions –3 and +5 of the 50 splice site
of hF1g intron 9 are diﬀerent. If these diﬀerent nucleotides
were substituted to match the consensus sequence, the
splicing of hF1g intron 9 was completely shifted to the
U1-dependent splicing. Finally, in vivo splicing assay
revealed that Fox-1 failed to induce hF1g exon 9 skipping
if the 50 splice site of intron 9 was mutated to the
U1-dependent type, or if a suppressor U1 snRNA that is
expected to base-pair with the 50 splice site was expressed.
Our results suggest that U1-independent splicing contri-
butes to the regulation of alternative splicing of a class of
pre-mRNAs.
MATERIALS AND METHODS
Invitro splicing and spliceosome purification
32P-labeled pre-mRNAs (2.5 10
4c.p.m.) were incubated
in 10ml of reaction mixture containing 1.6mM MgCl2,
0.5mM ATP, 20mM creatine phosphate and 30% HeLa
nuclear extracts and then terminated with proteinase K.
The splicing products were extracted and separated by
electrophoresis on 6% denaturing PAGE. For the puriﬁ-
cation of the E complex,
32P-labeled pre-mRNAs (12.5 
10
4c.p.m.) were incubated in 30ml mixture containing
30% ATP-depleted nuclear extracts with 1mg of GST-
MS2 protein. After 15min incubation at 308C, 3mlo f
the reaction mixture was set aside as the input control;
20ml of glutathione beads was added to the remaining
mixture, and the ﬁnal volume was brought to 200mlb y
the addition of NET2 buﬀer [50mM Tris (pH7.5),
150mM NaCl and 0.05% NP-40]. After a 2-h incubation
at 48C, the beads were washed six times with cold NET2
buﬀer and treated with proteinase K for RNA analysis.
RNA was recovered by phenol extraction and ethanol
precipitation, fractionated by 6% denaturing PAGE and
transferred to Biodyne Plus membrane (Pall).
Hybridization with
32P-labeled RNA probes for U1 and
U2 snRNAs were transcribed in vitro. For protein analy-
sis, the beads were boiled in SDS–PAGE sample buﬀer
and used for western blotting with anti-U1-70K anti-
body (17) or anti-U2AF65 anti-body (Sigma).
RNA microinjection into Xenopus oocytes
RNA microinjection experiments into Xenopus oocytes
were performed as described previously (18,19). Total
RNAs were recovered from the injected oocytes. Splicing
products were analyzed on the denatured gel and detected
by autoradiography. Northern blotting was also per-
formed to detect endogenous U1 and U2 snRNAs.
Transfectionexperiments
HeLa cells were grown in DMEM containing 10% FBS.
Transfection was performed by the Polyfect reagent
(QIAGEN). Transfected cells were usually incubated for
18h before RNA extraction, except U1 suppressor
experiments in which the transfected cells were incubated
for 48h. The myc fusion proteins expressed in transfected
cells were examined by western blotting using anti-myc
antibody (cMyc 9E10; Santa Cruz Biotechnology). As a
loading control of western blotting, U2AF65 was detected
by anti-U2AF65 antibody (Sigma). To analyze splicing
products from hF1g mini-gene by RT-PCR, F1-2903
and T7 primers were used as described previously (13).
Splicing eﬃciencies of exon 8–9 and exon 9–10 were ana-
lyzed by PCR using the same cDNA with SP6 and exon
8–9-AS primers and exon 9–10-S and T7 primers, respec-
tively. PCR products were electrophoresed in 5% native
PAGE, and visualized by a phosphorimager. Splicing pro-
ducts were quantiﬁed using NIH Image J software.
RESULTS AND DISCUSSION
U1 snRNP-independent Ecomplex isformed on thehF1c
exon 9–10
In our previous study, we showed that Fox-1 induces
the hF1g exon 9 skipping by interfering with the pre-
spliceosomal E complex formation on intron 9 (exon
9–10) (13). To further clarify the mechanism, we per-
formed aﬃnity puriﬁcation of the E complex formed on
hF1g exon 9–10 pre-mRNA fused with two MS2 binding
sites at the terminus of 30 exon (Figure 1A). The hF1g3GC
AUG pre-mRNA contains a portion of the preceding
intron 8 with three copies of the GCAUG element (Fox-
1 binding element). Note that the branch point in intron 8
was disrupted by base-substitution mutations. The GCAU
G elements were deleted in hF1gGCAUG pre-mRNA
(Figure 1A). We also used CDC14-15 (chicken d crystallin
exon 14–15) pre-mRNA with MS2-binding sites as a con-
trol substrate, which is often used for in vitro splicing anal-
yses (20,21). Under our in vitro splicing conditions, hF1g
pre-mRNAs were spliced as eﬃciently as CDC14-15 (see
Supplementary Figure S1).
For the pre-spliceosomal E complex puriﬁcation, the
pre-mRNAs were incubated in HeLa cell nuclear extracts
in the absence of ATP since the E complex formation does
not require ATP. The E complex formed on the substrate
RNA was then pulled down with GST-MS2 fusion pro-
tein. We analyzed the puriﬁed complexes by northern blot-
ting for detection of U1 and U2 snRNAs and also by
western blotting with U1-70K and U2AF65 antibodies.
As expected, a typical E complex, containing U1
snRNP, U2AF and U2 snRNP (5), was formed on the
CDC14-15 pre-mRNA (Figure 1B and C, lane 5). To
our surprise, however, U1 snRNP components were
barely detectable in the E complex formed on the hF1g
pre-mRNAs, although the complex contained U2AF and
U2 snRNP (Figure 1B and C, lanes 7 and 8). We con-
ﬁrmed that U4 and U6 were not included in the E complex
of hF1g, whereas these snRNAs as well as U2 were pres-
ent in the late splicing complexes that formed in the pres-
ence of ATP (Supplementary Figure S2). It has been
reported that Drosophila ftz pre-mRNA is spliced eﬃ-
ciently in the absence of U1 snRNP in vitro (16).
Consistently, we found that U1 snRNP was much less
detected in the E complex formed on the ftz pre-mRNA
1908 Nucleic Acids Research, 2009, Vol. 37,No. 6(Figure 1B and C, lane 6), although the pre-mRNA was
spliced eﬃciently (Supplementary Figure S1). These
results indicated that U1-independent E complex (herein-
after U1-E complex) is formed on the hF1g exon 9–10
irrespective of the presence of Fox-1-binding elements.
We compared the nucleotide sequences from –3 to +6
relative to the 50 splice site of these pre-mRNAs, which is
thought to aﬀect binding of U1 snRNA (Figure 1D). The
CDC14-15 has the same sequence with the consensus of
the canonical 50 splice site except the nucleotide at position
+6. As compared with CDC14-15, position +4 of the ftz
50 splice site is substituted by guanosine, and the positions
–3 and +5 of the hF1g 50 splice site are substituted by
guanosine and adenosine, respectively (Figure 1D).
Splicing ofthe hF1cexon9–10 pre-mRNA isnaturally
U1-independent
The hF1g exon 9–10 pre-mRNA formed U1-E complex
in vitro. Therefore, we assumed that it is spliced even in the
absence of U1 snRNP. At ﬁrst, we employed an in vitro
splicing system using U1 snRNP-inactivated HeLa cell
nuclear extracts. To inactivate U1 snRNP, HeLa nuclear
extracts were pretreated with antisense 20-O-methyl oligo-
nucleotide that was complementary to the 50 end of U1
snRNA (22). We found that the AdML pre-mRNA was
not spliced in the HeLa nuclear extracts lacking U1
snRNP as described previously (22–24) (Figure 2, lanes
1–4). Splicing of CDC14-15 pre-mRNA was also reduced,
although the pre-mRNA was less sensitive to
U1-inactivation (Figure 2, lanes 5–8). We conﬁrmed that
addition of antisense oligonucleotide against U1 snRNA
strongly inhibited the binding of U1 with the pre-mRNAs
(Supplementary Figure S3). Under the same condition,
however, ftz and hF1g exon 9–10 pre-mRNAs were
spliced eﬃciently (Figure 2, lanes 9–16).
To further examine if hF1g intron 9 is spliced in a
U1-independent manner, we performed microinjection
experiments of the RNA substrates into Xenopus oocytes,
in which U1 or U2 snRNP had been disrupted by the pre-
injection of an antisense oligonucleotide against U1 or U2
snRNA (18,19). Destruction of U1 and U2 by endogenous
RNase H activity was conﬁrmed by northern blotting.
U1 snRNA was truncated, whereas U2 was completely
destroyed (Figure 3A). Under these conditions, three
kinds of in vitro transcribed
32P-labeled pre-mRNAs,
CDC14-15, ftz and hF1g 9–10, were individually injected
into the nucleus of Xenopus oocytes. When U2 was dis-
rupted, splicing of these three pre-mRNAs was drastically
inhibited (Figure 3B, lanes 4, 8 and 12). In the case of U1
disruption, splicing of CDC14-15 pre-mRNA was strongly
inhibited (Figure 3B, lane 3). Nevertheless, ftz and hF1g
pre-mRNAs were eﬃciently spliced (Figure 3B, lanes 7
and 11). These results led us to conclude that hF1g exon
9–10 is a natural substrate of U1-independnt splicing and
that the U1-independece in the splicing reaction can be
correctly judged by the formation of U1-E complex.
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Figure 1. Puriﬁcation of the pre-spliceosomal E complex formed on hF1g exon 9–10 pre-mRNA in vitro.( A) The schematic representation of pre-
mRNAs, CDC14-15, ftz, hF1g3GCAUG and hF1gGCAUG, fused with two MS2-binding sites at the 30 exons. Boxes and lines represent exons and
introns, respectively. The Fox-1 binding element GCAUG is shown as a closed circle. (B) Northern blotting of the puriﬁed E complexes with U1 and
U2 snRNA probes (lanes 5–8) and aliquots of the reaction mixtures (lanes 1–4). Average and standard deviation (SD) of the ratio of U1 snRNA to
U2 snRNA from three independent experiments are shown at the bottom. (C) Western blotting of the puriﬁed E complexes on the pre-mRNAs using
U1-70K and U2AF65 antibodies (lanes 5–8) and aliquots of the reaction mixtures (lanes 1–4). (D) The sequences of 50 splice sites of four kinds of
pre-mRNAs as shown in (A). Capital and lowercase letters correspond to exonic and intronic residues, respectively. The nucleotide diﬀerent from the
consensus site is shown in bold.
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U1-independent splicing
To identify a cis-element that is required for
U1-independnet splicing, we constructed two chimeric
constructs of hF1g and CDC14-15, designated as 9–15
and 14–10, in which the 50 and 30 halves of hF1g
exon 9–10 were swapped with those of CDC14-15 in
the center of their introns (Figure S4A). The two
MS2-binding sites were also fused to the 30 termini of
transcripts. In vitro splicing experiments showed that the
chimeric pre-mRNAs as well as CDC14-15, hF1gGCAU
G, and hF1g exon 9–10 were spliced with a comparable
eﬃciency (Supplementary Figure S4C). Subsequently, the
E complex formed on these pre-mRNAs were puriﬁed and
subjected to northern blotting with probes for U1 and U2
snRNAs. We found that the E complexes of CDC14-15
and 14-10 contained U1 snRNA, whereas no U1 associa-
tion was observed with hF1gGCAUG, hF1g exon 9–10
and 9–15 pre-mRNAs, suggesting that the cis-element(s)
for U1-E complex formation lies in the 50 half region
of hF1g exon 9–10 (Supplementary Figure S4B). By intro-
duction of base-substitution mutations into the region
except the 50 splice site, however, we could not ﬁnd out
a speciﬁc cis-element that is indispensable for
U1-independent splicing (data not shown). Multiple ele-
ments may be involved.
The hF1g intron 9 possesses the typical GT-AG bound-
aries, although the 50 splice site has a suboptimal sequence
as compared with the consensus sequence, CAG/guaagu
(Figure 1D). The 50 splice site sequence of intron 9 has a
conserved sequence at least in humans, mice and bovine
(25). To examine if the 50 splice site sequence is crucial for
U1-independent splicing, two base-substitutions were
introduced (–3G>C and +5a>g) to change the hF1g 50
splice site sequence to that of CDC14-15 (Figure 4A).
The mutant was spliced eﬃciently as the parent substrate
in vitro (Figure 4C). Northern blotting showed that the
base-substitutions into the 50 splice site drastically led
0
U
1
U
2
F1γ9-10
- 0
U
1
U
2
Ftz
- 0
U
1
U
2
CDC14-15
- 0
U
1
U
2
AdML
-
1234 5678 91 01 11 2 13 14 15 16
Figure 2. hF1g exon 9–10 pre-mRNA is spliced eﬃciently in U1-inactivated HeLa nuclear extracts in vitro. Splicing reaction of AdML (lanes 1–4),
CDC14-15 (lanes 5–8), ftz (lanes 9–12) and hF1g 9–10 (lanes 13–16) with the normal HeLa cell nuclear extracts (lanes 2, 6, 10 and 14), the U1- (lanes
3, 7, 11 and 15) or U2-inactivated (lanes 4, 8, 12 and 16) extracts, as well as transcripts without incubation (lanes 1, 5, 9 and 13). Pre-mRNA,
intermediates and splicing products are indicated schematically on the right.
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Figure 3. Splicing of hF1g exon 9–10 pre-mRNA in U1- or U2-dis-
rupted Xenopus oocytes. (A) Northern blotting of endogenous U1 and
U2 snRNAs in Xenopus oocytes. Antisense oligonucleotide against U1
or U2 snRNA was injected into the cytoplasm of Xenopus oocytes to
disrupt endogenous U1 or U2. The same volume of water was injected
as a control (–). Note that U1 snRNA was truncated by the injection of
the U1 antisense oligo (the fast migrating band indicated as U1
 ), since
the oligo targets the 50 end of U1 snRNA. (B) Splicing of the
32P-
labeled CDC14-15, ftz and hF1g 9–10 pre-mRNAs in the nuclei of
control (lanes 2, 6 and 10), U1-disrupted (lanes 3, 7 and 11), or U2-
disrupted oocytes (lanes 4, 8 and 12). The hF1g 9–10 transcript lacks
the intron 8 sequence. RNA was analyzed immediately (lanes 1, 5 and
9) or at 70min (lanes 2–4, 6–8 and 10–12) after injection.
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(Figure 4B). These results strongly suggested that the posi-
tions at –3C and +5G of 50 splice site are important for
U1 snRNP binding.
In the 50 splice site sequence, the nucleotide at position
+5 is suggested to be important for base-pairing with
U1 snRNA as well as U6 snRNA (26–30). In the case
of Drosophila ftz pre-mRNA, which seems to be spliced
in a manner partly independent of U1 snRNP, position
+4, instead of +5, is substituted from the consensus
sequence (Figure 1D). Thus, it is unlikely that the primary
sequence of the 50 splice site is the only determinant
for U1-independent splicing. Crispino et al. (16) showed
that the sequences ﬂanking the 50 splice site of the ftz
pre-mRNA are necessary but not suﬃcient for
U1-independent splicing. Taken together, our current
model for U1-independent splicing is as follows. First,
the suboptimal 50 splice site is necessary for avoiding
tight base-pairing with U1 snRNA. Second, some trans-
acting factor may associate with the nearby cis-element for
deﬁnition of the 50 splice site, and then inducing U1-E
complex formation. However, we cannot exclude the pos-
sibility that the ﬂanking sequence functions to prevent U1
binding, for example, through a secondary structure (31).
Possible candidates for trans-acting factors in
U1-independent splicing include U6 snRNA and SR pro-
teins. It has been shown that several pre-mRNAs can be
spliced with high eﬃciency in U1-depleted nuclear extracts
enriched in SR proteins. Excess SR proteins form a com-
plex with the pre-mRNA and then promote the associa-
tion of U2 snRNP with the branch site in the absence
of U1 snRNP (14,15). However, our results show no
enhanced association of SR proteins with the hF1g and
ftz pre-mRNAs (data not shown). Moreover, U6 snRNP
was not detected in the E complex formed on the hF1g,
although it was included in the late splicing complexes
in vitro. Crispino and Sharp (32) reported that the base
pairing of the pre-mRNA with U6 snRNA, probably
during the binding of the U4/U5/U6 tri-snRNP, is a
rate-limiting step in U1-independent splicing. Thus, it is
unlikely that U6 functions as a cue for U1-E complex
formation, the initial step of U1-independent splicing.
Further investigation to identify the trans-acting factors
involved in U1-independent splicing will be necessary.
U1-independent splicing isindispensable forhF1cexon
9skippingby Fox-1
The biological role of U1-independent splicing remains
totally unknown. Previously, we showed that Fox-1
induced hF1g exon 9 skipping by repressing the splicing
of intron 9. Therefore we assumed that U1-independent
splicing plays a role in exon 9 skipping induced by Fox-1.
We veriﬁed this hypothesis by the following two kinds of
experiment.
First, we performed transfection experiments using
a mutant hF1g mini-gene, hF1gS3GCAUG (50SSmt), in
which the 50 splice site of intron 9 had been substituted to
that of CDC14-15, namely the U1-dependent splice site
(Figure 5A). Transfection assay of wild-type hF1g mini-
gene into HeLa cells showed that Fox-1 proteins pro-
moted exon 9 exclusion as described in our previous
report (13) (Figure 5B, lanes 1 and 2). It has been
shown that endogenous Fox-1 is undetectable in
HeLa cells (11). In contrast, when the mutant
mini-gene hF1gS3GCAUG (50SSmt) containing the
U1-dependent splice site was transfected, exon 9 exclusion
was barely observed even in the presence of Fox-1
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Figure 4. Role of the 50 splice site sequence in U1-independent
splicing. (A) Base-substitutions introduced into the 50 splice site
of hF1g3GCAUG pre-mRNA are shown (–3G>C and +5a>g).
Capital and lowercase letters correspond to exonic and intronic nucleo-
tides, respectively. Boxes and lines represent exons and introns, respec-
tively. The Fox-1 binding element GCAUG is shown as a closed circle.
(B) Northern blotting of the puriﬁed E complexes with U1 and U2
snRNA probes (lanes 5–8) and aliquots of the reaction mixtures
(lanes 1–4). (C) Splicing reaction of hF1g3GCAUG (lanes 1–3) and
hF1gmt50SS (lanes 4–6). These pre-mRNAs were incubated under the
standard in vitro splicing condition for indicated time above each lane.
Pre-mRNA, intermediates and splicing products are indicated schemat-
ically on the right.
Nucleic Acids Research,2009, Vol.37, No. 6 1911(Figure 5B, lanes 3 and 4). Note that the splicing eﬃcien-
cies of introns 8 and 9 were not largely aﬀected by the
mutation into the splice site in the absence of Fox-1
(lanes 5, 7, 9 and 11). Importantly, when the Fox-1 protein
was co-expressed (Figure 5D), splicing of the downstream
intron 9 (E9–E10) of wild-type hF1g mini-gene was inhib-
ited by Fox-1 as expected (13), whereas that of the mutant
mini-gene hF1gS3GCAUG (50SSmt) was not (Figure 5B,
lanes 9–12). Irrespective of the mutation into the 50 splice
site, splicing of intron 8 (E8–E9) was not aﬀected by the
Fox-1 expression (lanes 5–8). In addition, we conﬁrmed
that the expressed Fox-1 protein was properly localized to
the nucleus (data not shown).
Second, we examined the eﬀect of a suppressor U1
snRNA (30,33), which is expected to stably base pair
with the intact 50 splice site in intron 9 (Figure 5A). In
the absence of Fox-1, the suppressor U1 snRNA did not
largely aﬀect the spicing eﬃciencies of introns 8 and 9
as compared with the wild-type U1 snRNA expression
(Figure 5C, lanes 1, 3, 5, 7, 9 and 11). However, the
exon 9 skipping induced by Fox-1 was disrupted to
some extent by the suppressor U1 snRNA expression
(Figure 5C, lanes 4, 8 and 12).
These results led us to conclude that U1-independent
splicing of hF1g intron 9 is indispensable for induction
of exon 9 skipping by Fox-1. It is possible that Fox-1
inhibits the association of some trans-acting factor for
U1-E complex formation with the hF1g pre-mRNA.
Role of U1-independent splicing
Our study implies that there exist a number of
U1-independent introns in mammalian genomes.
Recently, Raponi and Baralle (34) proposed a possibility
that U1-independent splicing could be disrupted by some
disease-causing mutations in the 50 splice site.
Our study showed that U1-independent splicing of
hFg intron 9 requires U2 snRNP. A class of minor
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Figure 5. U1-independent splicing is indispensable for the regulation of alternative splicing of hF1g by Fox-1. (A) The schematic representation of
wild-type (WT) and mutant (mtU1) hF1g mini-genes (left) and the suppressor U1 snRNP (right). The mutations introduced into the 50 splice site of
exon 9 are underlined. Closed circles indicate the Fox-1 binding element. (B) Transfection assay of hF1g WT and 50SSmt mini-genes co-expressed
with pCS2+MT vector or pCS+MT-Fox-1 in HeLa cells. The left panel shows spliced products ampliﬁed by the oligonucleotides annealed with
exons 8 and 10. The middle and right panels show the splicing reaction between exons 8 and 9 and between exons 9 and 10. Positions of splicing
products and unspliced transcripts are schematically shown on the right. All experiments were independently performed four times. Average and
standard deviation of exon 9 exclusion and splicing eﬃciency are shown at the bottom of each lane. (C) Suppressor U1 snRNA experiments in HeLa
cells. The wild-type or mutant U1 snRNA was co-expressed with wild-type hF1g mini-gene and pCS2+MT vector or pCS+MT-Fox-1. The spliced
products were analyzed by RT-PCR using the oligonucleotides annealed with exons 8 and 10 (left panel), exons 8 and 9 (middle panel) and exons 9
and 10 (right panel). Positions of splicing products and unspliced transcripts are schematically shown on the right. All experiments were indepen-
dently performed three times. Average and standard deviation of exon 9 exclusion and splicing eﬃciency are shown at the bottom of each lane. (D)
Western blotting of cell extracts using the anti-Myc antibody (upper panel) and anti-U2AF65 antibody as a loading control (lower panel). Molecular
size markers are shown on the right.
1912 Nucleic Acids Research, 2009, Vol. 37,No. 6introns, AT-AC introns, having noncanonical splice sites
are spliced by U12-type spliceosome (35). The 50 splice site
of AT-AC intron was recognized by base pairing with U11
snRNP that is diﬀerent from U1 snRNP but functionally
analogous to the U1 snRNP. Thus, it is possible that
U11-independent splicing may take place in a subset of
AT-AC introns.
U1-independent splicing may be necessary for the spli-
cing regulation of other genes by Fox-1 and also by other
splicing regulators. Fox-1 and Fox-2 function as both neg-
ative and positive splicing regulators (10–12,36). Our
study suggests that U1-independent splicing may be
involved at least in the negative regulation of alternative
splicing by Fox proteins.
It has been shown that U1 snRNP often plays key roles
in the splicing regulation. The association of U1 snRNP to
the alternative exons is promoted by SR proteins and sev-
eral regulators such as TIA-1 and HMGA-1 (6,8,37). Shin
et al. (38,39) reported that mRNA splicing is downregu-
lated through the inhibition of U1 snRNP function by
SRp38 dephoshorylated during mitosis and also in
response to heat shock (37,38). It should be clariﬁed if
U1-independent splicing is also inhibited under such
conditions.
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